Europe Viral Vector Purification Market, By Product & Services (Products and Services), Type (Retroviral Vectors, Vaccine Virus, Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentivirus and Other), Workflow (Upstream Processing and Downstream Processing), Purification Technique (Density-Gradient Ultracentrifugation, Ultrafiltration, Precipitation, Two-Phase Extraction Systems and Chromatography), Scale of Operation (Preclinical / Clinical and Commercial), Delivery Method (In Vivo and Ex Vivo), Disease Indication (Cancer, Genetic Disorders, Infectious Diseases, Veterinary Disease and Other), Application (Antisense & RNAi, Gene Therapy, Cell Therapy and Vaccinology), End User (Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations, Contract Development and Manufacturing Organization (CDMO) and Academic/ Research Institutes), Country (U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Rest of Europe) Industry Trends and Forecast to 2028
Market Analysis and Insights : Europe Viral Vector Purification Market
The viral vector purification market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 14.5% in the forecast period of 2021 to 2028 and is expected to reach USD 367.36 million by 2028. Rising demand for viral vectors is acting as a driver for the viral vector purification market
Molecular biologists frequently use viral vectors to deliver genetic material into cells. This procedure can be carried out in vivo (inside a living organism) or in cell culture (in vitro). Viruses have developed specialized molecular mechanisms to transport their genomes efficiently inside the cells they infect. Transduction is the delivery of genes or other genetic material by a vector and infected cells are referred to as transduced.
Emergence of COVID-19 and demand for viral vaccine is boosting the viral vector purification market. Lack of scalability is a restraint for the viral vector purification market. Rising number of infectious disease act as an opportunity for the viral vector purification market. Shortage of skilled personnel is a challenge for the viral vector purification market.
The viral vector purification market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the viral vector purification market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Viral Vector Purification Market Scope and Market Size
The viral vector purification market is categorized into nine notable segments which are based on the product & services, type, workflow, purification technique, scale of operation, delivery method, disease indication, application and end user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of product & services, the viral vector purification market is segmented into products and services. In 2021, products segment is expected to dominate the viral vector purification market due to availability of diverse range of innovative solutions for vector purification.
- On the basis of type, the viral vector purification market is segmented into retroviral vectors, vaccine virus, adenoviral vectors, adeno-associated viral vectors, lentivirus and other. In 2021, adeno-associated viral vectors segment is expected to dominate the viral vector purification market due to broad range of infectivity of AAV.
- On the basis of workflow, the viral vector purification market is segmented into upstream processing and downstream processing. In 2021, upstream processing segment is expected to dominate the viral vector purification market because the viral vectors produced using this process can be harvested from cells in a short window of time post transfection.
- On the basis of purification technique, the viral vector purification market is segmented into density-gradient ultracentrifugation, ultrafiltration, precipitation, two-phase extraction systems and chromatography. In 2021, chromatography segment is expected to dominate the viral vector purification market because it has been widely used for purification of vaccines and gene therapy vectors.
- On the basis of scale of operation, the viral vector purification market is segmented into preclinical / clinical and commercial. In 2021, preclinical / clinical segment is expected to dominate the viral vector purification market due to rising investment for research and development activities by major healthcare organizations.
- On the basis of delivery method, the viral vector purification market is segmented into in vivo and ex vivo. In 2021, in vivo segment is expected to dominate the viral vector purification market due to its high availability and process reliability.
- On the basis of disease indication, the viral vector purification market is segmented into cancer, genetic disorders, infectious diseases, veterinary disease and other. In 2021, genetic disorders segment is expected to dominate the viral vector purification market owing to the rising incidence and prevalence of genetic disorders.
- On the basis of application, the viral vector purification market is segmented into antisense & RNAi, gene therapy, cell therapy and vaccinology. In 2021, gene therapy segment is expected to dominate the viral vector purification market due to broad range of applications in medical sector.
- On the basis of end user, the viral vector purification market is segmented into biotechnology companies, pharmaceutical companies, contract research organizations, contract development and manufacturing organization (CDMO) and academic/ research institutes. In 2021, academic/ research institutes segment is expected to dominate the viral vector purification market due to increasing initiative activities by various healthcare organizations and government bodies to encourage research endeavour.
Europe Viral Vector Purification Market Country Level Analysis
Europe viral vector purification market is analysed and market size information is provided by the country, product & services, type, workflow, purification technique, scale of operation, delivery method, disease indication, application and end user as referenced above.
The countries covered in the Europe viral vector purification market report are U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Rest of Europe.
Europe is expected to grow with the significant growth rate in the forecast period of 2021 to 2028 due to high technology based healthcare infrastructure and increasing healthcare expenditure in the region. Germany is dominating the European market with the increasing advancement in Viral vector purification’ industry in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europebrands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Strategic Initiatives by Manufacturers is Creating New Opportunities for Players in the Viral Vector Purification Market
The viral vector purification market also provides you with detailed market analysis for every country growth. Moreover, it provides detail data regarding growth in viral vector purification sales, partnership, acquisition, distribution agreements among the viral vector purification market players of European region. The data is available for historic period 2010 to 2019.
Competitive Landscape and Viral Vector Purification Market Share Analysis
The viral vector purification market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to viral vector purification market.
The major players covered in the Europe viral vector purification market report are Applied Biological Materials Inc., Creative Biolabs, Bio-Rad Laboratories, Inc., Sirion-Biotech GmbH, Merck KGaA, Batavia Biosciences B.V., Agilent Technologies, Inc., Addgene, Takara Bio Inc., Thermo Fisher Scientific Inc., uniQure N.V., BioVision Inc., Cytiva (a subsidiary of Danaher) among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many contracts and agreements are also initiated by the companies’ worldwide which are also accelerating the viral vector purification market.
For instance,
- In January 2021, Thermo Fisher Scientific Inc. announced that it has completed the acquisition of Novsep’s viral vector manufacturing business in Belgium which will help the company to further diversify its market.
Collaboration, joint ventures and other strategies by the market players is enhancing the company impression in the viral vector purification market which also provides the benefit for organisation to improve their sales growth.
SKU-